Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "U.S.-National-Institutes-of-Health"

1 News Found

Bavarian Nordic receives EMA approval of mpox vaccine for adolescents
Drug Approval | September 23, 2024

Bavarian Nordic receives EMA approval of mpox vaccine for adolescents

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA